Distress Screening Through Patient-Reported Outcomes Measurement Information System (PROMIS) at an Academic Cancer Center and Network Site: Implementation of a Hybrid Model
Abstract:PURPOSE: Cancer care guidelines recommend regular distress screening of patients, with approximately one in three patients with cancer experiencing significant distress. However, the implementation of such programs is variable and inconsistent. We sought to assess the feasibility of implementing a hybrid electronic and paper screening tool for distress in all patients coming to a large academic cancer center and an associated integrated network site. METHODS: Patients at an academic cancer center (Stanford Can… Show more
“…If shown to be concurrently valid, PROMIS may adequately replace PROMs and reduce both patient and physician burden. Previous studies have found that PROMIS sufficiently captures information obtained through disease-specific PROMs 4,5,14–16 . PROMIS is unique in that it utilizes an iterative CAT system, based on item response theory that improves flexibility, sensitivity, and efficiency 13 .…”
Section: Discussionmentioning
confidence: 99%
“…Disease specific PROMs and the more generic PROMIS instrument are increasingly used in spine and oncological patients. [15][16][17] PROMIS provides insight into a patient's health across a variety of health conditions and may therefore capture information provided by various disease specific PROMs. 18,19 If shown to be concurrently valid, PROMIS may adequately replace PROMs and reduce both patient and physician burden.…”
In this cross-sectional prospective study, SOSG-OQ was strongly correlated with PROMIS PI (ρ = 0.78) and PROMIS PF (ρ = 0.71), and moderately correlated with PROMIS Depression (ρ = 0.58). Spine surgeons can consider using PROMIS domains in lieu of the SOSG-OQ in metastatic spine tumor patients.
“…If shown to be concurrently valid, PROMIS may adequately replace PROMs and reduce both patient and physician burden. Previous studies have found that PROMIS sufficiently captures information obtained through disease-specific PROMs 4,5,14–16 . PROMIS is unique in that it utilizes an iterative CAT system, based on item response theory that improves flexibility, sensitivity, and efficiency 13 .…”
Section: Discussionmentioning
confidence: 99%
“…Disease specific PROMs and the more generic PROMIS instrument are increasingly used in spine and oncological patients. [15][16][17] PROMIS provides insight into a patient's health across a variety of health conditions and may therefore capture information provided by various disease specific PROMs. 18,19 If shown to be concurrently valid, PROMIS may adequately replace PROMs and reduce both patient and physician burden.…”
In this cross-sectional prospective study, SOSG-OQ was strongly correlated with PROMIS PI (ρ = 0.78) and PROMIS PF (ρ = 0.71), and moderately correlated with PROMIS Depression (ρ = 0.58). Spine surgeons can consider using PROMIS domains in lieu of the SOSG-OQ in metastatic spine tumor patients.
“…Patient-reported improvements in mental health (GMH) in this study were especially noteworthy. Mental health support is critical considering that up to 65% of individuals with cancer report high levels of distress and depressive or anxious symptoms [17,[58][59][60]. In some cases, high levels of distress are related to unplanned healthcare use [61] and decreased adherence to cancer treatments [62].…”
Compared to adults without cancer, cancer survivors report poorer health-related quality of life (HRQOL), which is associated with negative treatment outcomes and increased healthcare use. Cancer-specialized physical and occupational therapy (PT/OT) could optimize HRQOL; however, the impact among survivors with non-breast malignancies is unknown. This retrospective (2020–2022), observational, study of medical record data of 12 cancer types, examined pre/post-HRQOL among cancer survivors who completed PT/OT. PROMIS® HRQOL measures: Global Health (physical [GPH] and mental [GMH]), Physical Function (PF), and Ability to Participate in Social Roles and Activities (SRA) were evaluated using linear mixed effect models by cancer type, then compared to the minimal important change (MIC, 2 points). Survivors were 65.44 ± 12.84 years old (range: 19–91), male (54%), with a median of 12 visits. Improvements in GPH were significant (p < 0.05) for all cancer types and all achieved MIC. Improvements in GMH were significant for 11/12 cancer types and 8/12 achieved MIC. Improvements in PF were significant for all cancer types and all achieved the MIC. Improvements in SRA were significant for all cancer types and all groups achieved the MIC. We observed statistically and clinically significant improvements in HRQOL domains for each of the 12 cancer types evaluated.
“…Further, PROMIS domains demonstrated greater reliability over a broader range of symptom severity or functional impairment compared with SF-12 or SF-36 (31,32). The precise, versatile PROMIS item banks (administered either as four-or eight-item short forms, or computer adaptive test) have also already been used as outcome measures studies (33,34) and in clinical practice for symptom monitoring (35)(36)(37). In addition, PROPr, and the overall mental and physical health summary scores (38), provide reliable measures of health utility and overall HRQOL.…”
Section: Discussionmentioning
confidence: 99%
“…We calculated PROPr using scores generated from seven domains that may be assessed by PROMIS short forms and computer adaptive tests. These seven domains, as well as the total number of items included in the respective item banks, are as follows: depression (28), fatigue (95), physical function (165), sleep disturbance (27), ability to participate in social roles and activities (35), pain interference (40), and cognitive function abilities (31). The PROMIS short-form profiles PROMIS-57, PROMIS-43, and PROMIS-29 assess each domain using eight, six, or four items, respectively.…”
Background and Objectives A preference-based health utility score (PROPr) can be calculated using Patient-Reported Outcomes Measurement Information System domain scores. We assessed the construct validity of PROPr among patients treated with kidney replacement therapy (hemodialysis or kidney transplant).
Design, setting, participants and measurements Secondary analysis of data collected in multicenter, cross-sectional studies of adults treated with kidney replacement therapy, recruited between April 2016 to March 2020 in Toronto, Canada. All participants provided informed consent. The outcome was PROPr score. Co-administered outcome variables included the Short form 6-domain (SF-6D) and EuroQol 5-domain 5-level (EQ-5D-5L) scores. Socioeconomic and clinical variables included age, sex, diabetes, estimated Glomerular Filtration Rate (eGFR), serum albumin, hemoglobin, kidney replacement therapy and Charlson-comorbidity index. Construct validity was assessed through correlations between PROPr and SF-6D or EQ-5D-5L and associations between PROPr and other exposure variables. Health condition impact estimates (coefficients for health conditions compared to a referent category: e.g. dialysis vs kidney transplant) were calculated using multivariable linear regression.
Results Mean (SD) age of the 524 participants was 57 (17) years, 58% were male and 45% white. Median (IQR) score was 0.39 (0.24-0.58) for PROPr, 0.69 (0.58-0.86) for SF-6D and 0.85 (0.70-0.91) for EQ-5D-5L. Large correlations were observed between PROPr vs SF-6D (0.79, 95%CI: 0.76 - 0.82) and EQ-5D-5L (0.71, 95%CI: 0.66 - 0.75). Both PROPr and the other utility indices demonstrated health condition impact in the expected direction. For example, the estimate for PROPr was -0.17 (95%CI: -0.13, -0.21) for dialysis (versus kidney transplant), -0.05 (95%CI: -0.11, 0.01, P=0.08) for kidney transplant recipients with eGFR <45 vs ≥45 ml/min/1.73m2 and -0.28 (95%CI: -0.22, -0.33) for moderate/severe versus no/mild depressive symptoms.
Conclusions Our results support the validity of PROPr among patients treated with kidney replacement therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.